We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.56B
AUM Growth
-$55.1M
Cap. Flow
-$126M
Cap. Flow %
-8.07%
Top 10 Hldgs %
43.87%
Holding
66
New
8
Increased
2
Reduced
52
Closed

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$906K
2
DUK icon
Duke Energy
DUK
+$666K
3
JNJ icon
Johnson & Johnson
JNJ
+$567K
4
ACN icon
Accenture
ACN
+$344K
5
DIS icon
Walt Disney
DIS
+$244K

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$6.97M
2
MRK icon
Merck
MRK
+$6.79M
3
UNH icon
UnitedHealth
UNH
+$6.62M
4
XOM icon
ExxonMobil
XOM
+$6.55M
5
WMT icon
Walmart Inc
WMT
+$6.39M

Sector Composition

Rank Sector Weight
1 Industrials 19.18%
2 Healthcare 15.87%
3 Financials 14.58%
4 Energy 13.12%
5 Consumer Staples 12.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$383B
$77.4M 4.96%
483,770
-44,303
-8% -$6.62M
VZ icon
2
Verizon
VZ
$193B
$76.9M 4.93%
1,440,326
-125,698
-8% -$6.28M
WMT icon
3
Walmart Inc
WMT
$884B
$73.6M 4.72%
3,194,922
-273,903
-8% -$6.39M
XOM icon
4
ExxonMobil
XOM
$651B
$73.5M 4.71%
814,269
-74,940
-8% -$6.55M
EXC icon
5
Exelon
EXC
$46.6B
$72.4M 4.64%
2,859,868
-293,977
-9% -$6.97M
MRK icon
6
Merck
MRK
$321B
$69M 4.42%
1,227,762
-116,058
-9% -$6.79M
ALL icon
7
Allstate
ALL
$68.3B
$68.6M 4.4%
925,213
-78,056
-8% -$5.5M
CVX icon
8
Chevron
CVX
$383B
$65.5M 4.2%
556,403
-50,573
-8% -$5.51M
PFE icon
9
Pfizer
PFE
$142B
$56M 3.59%
1,818,630
-159,707
-8% -$4.88M
DD icon
10
DuPont de Nemours
DD
$18.7B
$51.5M 3.3%
355,076
-29,064
-8% -$4.05M
TGT icon
11
Target
TGT
$65.6B
$49.8M 3.19%
689,453
-62,753
-8% -$4.54M
CAT icon
12
Caterpillar
CAT
$373B
$47.8M 3.07%
515,624
-45,998
-8% -$4.17M
CSCO icon
13
Cisco
CSCO
$448B
$46.1M 2.95%
1,524,193
-117,646
-7% -$3.59M
GD icon
14
General Dynamics
GD
$103B
$45.2M 2.9%
261,868
-21,448
-8% -$3.51M
PG icon
15
Procter & Gamble
PG
$335B
$37.9M 2.43%
451,264
-40,910
-8% -$3.49M
WFC icon
16
Wells Fargo
WFC
$258B
$37.3M 2.39%
677,274
-61,788
-8% -$3.11M
JPM icon
17
JPMorgan Chase
JPM
$933B
$29.4M 1.89%
340,746
-30,799
-8% -$2.35M
RTN
18
DELISTED
Raytheon Company
RTN
$29.1M 1.87%
205,246
-16,955
-8% -$2.41M
IBM icon
19
IBM
IBM
$209B
$26.9M 1.72%
169,359
-8,321
-5% -$1.27M
SO icon
20
Southern Company
SO
$109B
$26.7M 1.71%
542,018
-43,480
-7% -$2.14M
BNY
21
Bank of New York Mellon
BNY
$106B
$25.8M 1.66%
545,510
-49,708
-8% -$2.24M
EMR icon
22
Emerson Electric
EMR
$83.3B
$25.5M 1.63%
457,087
-33,435
-7% -$1.8M
HON icon
23
Honeywell
HON
$76.7B
$25.2M 1.61%
240,350
-23,180
-9% -$2.36M
MDLZ icon
24
Mondelez International
MDLZ
$80.5B
$24.8M 1.59%
559,836
-52,936
-9% -$2.28M
AIG icon
25
American International
AIG
$41.8B
$23.7M 1.52%
362,900
-32,975
-8% -$2.07M

Similar funds

Edgar Lomax Company's Q4 2016 Portfolio in Review

As of Q4 2016, Edgar Lomax Company held 66 positions worth $1.56B, down 3.4% from $1.61B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Edgar Lomax Company withdrew a net $126M in Q4 2016, reducing 52 holdings. Its largest reduction was Exelon, cutting an estimated $6.97M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Edgar Lomax Company opened a new position in CVS Health worth $884K.

  • Edgar Lomax Company's largest Q4 2016 buy was CVS Health: 11,200 shares worth $884K.
  • Edgar Lomax Company added most to AT&T in Q4 2016, an estimated $164K increase.
  • Edgar Lomax Company's biggest Q4 2016 reduction was Exelon, cutting an estimated $6.97M.
  • Edgar Lomax Company's ten largest holdings make up 44% of its $1.56B portfolio in Q4 2016.
  • Edgar Lomax Company opened 8 new positions and closed 0 in Q4 2016.
  • Edgar Lomax Company's portfolio value fell 3.4% quarter-over-quarter to $1.56B.

Based on Edgar Lomax Company's 13F filing for Q4 2016, filed 13 Feb 2017.